Live Case from Medizinische Klinik, St. Johannes Hospital Dortmund | Dortmund, Germany

Monday, February 27, 2023

8:55 AM – 9:40 AM ET

Live Case Operator(s)

Johannes Blumenstein, MD

Attendent
St. Johannes-Hospital
Dortmund, Nordrhein-Westfalen, Germany

Disclosure(s): No financial relationships to disclose
Christina Grothusen, MD

St. Johannes-Hospital
Dortmund, Nordrhein-Westfalen, Germany

No relationships to disclose

Moderator(s)

Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Kendra J. Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States

Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

Panel Discussant(s)

Isida Byku, MD

Assistant Professor, Interventional/Structural Cardiology
Emory University Hospital

No relationships to disclose
Adnan Chhatriwalla, MD

Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States

Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Proctor (Ongoing), Speakers' Bureau (Ongoing); Medtronic, Inc.: Proctor (Ongoing), Speakers' Bureau (Ongoing)
Eberhard Grube, MD, FSCAI

Head CIIC
University Hospital Bonn
Siegburg, Nordrhein-Westfalen, Germany

Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)
Howard C. Herrmann, MD, FACC, MSCAI

Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Hasan A. Jilaihawi, MD (he/him/his)

Acting Associate Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure(s): Cedars-Sinai Medical Center: Employee (Ongoing); Medtronic: Consultant (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No relevant disclosure to display
Paul D. Mahoney, MD, FACC

Director, Structural Heart Program
Sentara Health
Norfolk, Virginia, United States

Disclosure(s): No relevant disclosure to display
Helge Moellmann, MD

Director Dept. of Cardiology
St.-Johannes-Hospital Dortmund
Dortmund, Nordrhein-Westfalen, Germany

No relationships to disclose
Shigeru Saito, MD, FACC, FSCAI

, Director of Cardiology & Catheterization Laboratories
Shonan Kamakura General Hospital
Kamakura, Kanagawa, Japan

Disclosure(s): Abbott Structural: Honoraria (Ongoing), Proctoring (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Proctoringring (Ongoing); Elixir: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Honoraria (Ongoing), Proctoring (Ongoing)
Robert Stoler, MD

Director-Cardiac Catheterization Lab. Co-Chief of Cardiology
Baylor Heart & Vascular Hospital Baylor University Medical Center
Dallas, Texas, United States

Disclosure(s): Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing); Boston Scientific: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing)

Disclosure(s):

Johannes Blumenstein, MD: No financial relationships to disclose

Kendra J. Grubb, MD: 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Michael J. Reardon, MD: Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

Adnan Chhatriwalla, MD: Abbott Vascular: Speakers' Bureau (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Proctor (Ongoing), Speakers' Bureau (Ongoing); Medtronic, Inc.: Proctor (Ongoing), Speakers' Bureau (Ongoing)

Eberhard Grube, MD, FSCAI: Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

Howard C. Herrmann, MD, FACC, MSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Hasan A. Jilaihawi, MD: Cedars-Sinai Medical Center: Employee (Ongoing); Medtronic: Consultant (Ongoing)

Samir R. Kapadia, MD, FSCAI: No relevant disclosure to display

Paul D. Mahoney, MD, FACC: No relevant disclosure to display

Shigeru Saito, MD, FACC, FSCAI: Abbott Structural: Honoraria (Ongoing), Proctoring (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Proctoringring (Ongoing); Elixir: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Honoraria (Ongoing), Proctoring (Ongoing)

Robert Stoler, MD: Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing); Boston Scientific: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Honoraria (Ongoing)